Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC) today announced its financial results ...
AMT-191 has been granted both Orphan Drug and Fast Track designation by the U.S. Food and Drug Administration.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果